Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05071716
Other study ID # RNLC3131
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date April 7, 2022
Est. completion date September 2025

Study information

Verified date March 2024
Source Bausch Health Americas, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study RNLC3131 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 524
Est. completion date September 2025
Est. primary completion date September 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Key Inclusion Criteria: - Diagnosis of liver cirrhosis with medically controlled ascites (>30 days) not requiring therapeutic paracentesis (could have had paracentesis in the past). - Conn (West Haven Criteria) score of < 2. - Mini-Mental State Examination (MMSE) score > 24 at screening. - = 18 and = 85 years of age. Key Exclusion Criteria: - Active COVID-19 that is unresolved - History of SBP - History of EVB or AKI-HRS within 6 months - History of OHE episode (Conn score = 2)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Rifaximin SSD
Rifaximin Solid Soluble Dispersion Immediate Release Twice Daily
Placebo
Placebo Twice Daily

Locations

Country Name City State
Australia Bausch Site 306 Bedford Park South Australia
Australia Bausch Site 304 Box Hill Victoria
Australia Bausch Site 307 Concord New South Wales
Australia Bausch Site 300 Kingswood New South Wales
Australia Bausch Site 305 Murdoch Western Australia
Australia Bausch Site 302 Parkville Victoria
Australia Bausch Site 303 Perth Western Australia
Canada Bausch Site 202 Edmonton Alberta
Canada Bausch Site 201 Toronto Ontario
Canada Bausch Site 203 Toronto Ontario
Puerto Rico Bausch Site 234 San Juan
United States Bausch Site 216 Albuquerque New Mexico
United States Bausch Site 136 Ann Arbor Michigan
United States Bausch Site 219 Atlanta Georgia
United States Bausch Site 215 Augusta Georgia
United States Bausch Site 221 Austin Texas
United States Bausch Site 164 Bakersfield California
United States Bausch Site 117 Baltimore Maryland
United States Bausch Site 237 Baton Rouge Louisiana
United States Bausch Site 132 Boston Massachusetts
United States Bausch Site 161 Boston Massachusetts
United States Bausch Site 223 Boston Massachusetts
United States Bausch Site 220 Bradenton Florida
United States Bausch Site 151 Bristol Connecticut
United States Bausch Site 146 Burlington Massachusetts
United States Bausch Site 257 Cape Coral Florida
United States Bausch Site 129 Chandler Arizona
United States Bausch Site 104 Charleston South Carolina
United States Bausch Site 217 Charlotte North Carolina
United States Bausch Site 194 Chicago Illinois
United States Bausch Site 196 Chula Vista California
United States Bausch Site 226 Chula Vista California
United States Bausch Site 114 Cleveland Ohio
United States Bausch Site 152 Clive Iowa
United States Bausch Site 154 Columbus Ohio
United States Bausch Site 197 Cutler Bay Florida
United States Bausch Site 107 Dallas Texas
United States Bausch Site 122 Dallas Texas
United States Bausch Site 133 Dallas Texas
United States Bausch Site 144 Dallas Texas
United States Bausch Site 260 Dalton Georgia
United States Bausch Site 167 Dayton Ohio
United States Bausch Site 123 Denison Texas
United States Bausch Site 137 Detroit Michigan
United States Bausch Site 265 Detroit Michigan
United States Bausch Site 182 Dothan Alabama
United States Bausch Site 192 Durham North Carolina
United States Bausch Site 251 East Brunswick New Jersey
United States Bausch Site 198 El Paso Texas
United States Bausch Site 143 Englewood Colorado
United States Bausch Site 174 Escondido California
United States Bausch Site 249 Fort Myers Florida
United States Bausch Site 172 Fort Worth Texas
United States Bausch Site 210 Fort Worth Texas
United States Bausch Site 163 Fresno California
United States Bausch Site 242 Garden Grove California
United States Bausch Site 230 Glen Burnie Maryland
United States Bausch Site 258 Harlingen Texas
United States Bausch Site 173 Hialeah Florida
United States Bausch Site 238 Hialeah Gardens Florida
United States Bausch Site 235 Hollywood Florida
United States Bausch Site 211 Homestead Florida
United States Bausch Site 261 Houma Louisiana
United States Bausch Site 130 Houston Texas
United States Bausch Site 158 Houston Texas
United States Bausch Site 159 Houston Texas
United States Bausch Site 170 Houston Texas
United States Bausch Site 229 Houston Texas
United States Bausch Site 239 Houston Texas
United States Bausch Site 120 Indianapolis Indiana
United States Bausch Site 139 Inverness Florida
United States Bausch Site 135 Iowa City Iowa
United States Bausch Site 148 Jackson Mississippi
United States Bausch Site 138 Jacksonville Florida
United States Bausch Site 184 Johnson City Tennessee
United States Bausch Site 178 Kansas City Missouri
United States Bausch Site 115 La Jolla California
United States Bausch Site 241 Lakewood Ranch Florida
United States Bausch Site 141 Lancaster California
United States Bausch Site 150 Little Rock Arkansas
United States Bausch Site 212 Littleton Colorado
United States Bausch Site 140 Los Angeles California
United States Bausch Site 189 Los Angeles California
United States Bausch Site 124 Louisville Kentucky
United States Bausch Site 231 Manassas Virginia
United States Bausch Site 126 Marietta Georgia
United States Bausch Site 134 Marrero Louisiana
United States Bausch Site 185 Mentor Ohio
United States Bausch Site 252 Mesquite Texas
United States Bausch Site 147 Miami Florida
United States Bausch Site 157 Miami Florida
United States Bausch Site 166 Miami Florida
United States Bausch Site 218 Miami Florida
United States Bausch Site 224 Miami Florida
United States Bausch Site 240 Miami Florida
United States Bausch Site 243 Miami Florida
United States Bausch Site 244 Miami Florida
United States Bausch Site 255 Miami Florida
United States Bausch Site 263 Miami Florida
United States Bausch Site 264 Miami Florida
United States Bausch Site 266 Miami Florida
United States Bausch Site 268 Miami Florida
United States Bausch Site 105 Milwaukee Wisconsin
United States Bausch Site 253 Minneapolis Minnesota
United States Bausch Site 271 Minneapolis Minnesota
United States Bausch Site 270 Moore Oklahoma
United States Bausch Site 127 Murray Utah
United States Bausch Site 181 Nashville Tennessee
United States Bausch Site 233 New Bedford Massachusetts
United States Bausch Site 118 New Orleans Louisiana
United States Bausch Site 186 New Port Richey Florida
United States Bausch Site 109 New York New York
United States Bausch Site 116 New York New York
United States Bausch Site 225 New York New York
United States Bausch Site 191 Newark New Jersey
United States Bausch Site 175 Norfolk Virginia
United States Bausch Site 227 Orange California
United States Bausch Site 213 Orlando Florida
United States Bausch Site 199 Pasadena California
United States Bausch Site 195 Pearland Texas
United States Bausch Site 267 Pembroke Pines Florida
United States Bausch Site 103 Peoria Arizona
United States Bausch Site 110 Philadelphia Pennsylvania
United States Bausch Site 153 Phoenix Arizona
United States Bausch Site 180 Phoenix Arizona
United States Bausch Site 228 Pittsburgh Pennsylvania
United States Bausch Site 256 Plantation Florida
United States Bausch Site 119 Redwood City California
United States Bausch Site 102 Rialto California
United States Bausch Site 111 Richmond Virginia
United States Bausch Site 113 Richmond Virginia
United States Bausch Site 177 San Diego California
United States Bausch Site 171 San Francisco California
United States Bausch Site 214 San Jose California
United States Bausch Site 250 Sayre Pennsylvania
United States Bausch Site 155 Seattle Washington
United States Bausch Site 269 Statesville North Carolina
United States Bausch Site 247 Sugar Land Texas
United States Bausch Site 262 Sugar Land Texas
United States Bausch Site 248 Tempe Arizona
United States Bausch Site 246 Texas City Texas
United States Bausch Site 128 Topeka Kansas
United States Bausch Site 222 Tucson Arizona
United States Bausch Site 183 Upland California
United States Bausch Site 272 Venice Florida
United States Bausch Site 193 Waco Texas
United States Bausch Site 188 Weston Florida
United States Bausch Site 245 Wilmington North Carolina
United States Bausch Site 273 Wilmington North Carolina
United States Bausch Site 149 Wyoming Michigan

Sponsors (1)

Lead Sponsor Collaborator
Bausch Health Americas, Inc.

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Puerto Rico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to first event of overt hepatic encephalopathy requiring hospitalization 72 weeks
Secondary Time to first Conn score = 2 72 weeks
Secondary Time to all-cause hospitalization 72 weeks
Secondary Time to first event of OHE that requires hospitalization, or all-cause death 72 weeks
See also
  Status Clinical Trial Phase
Completed NCT01559519 - Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy Phase 4
Terminated NCT01846806 - The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. N/A
Recruiting NCT01178372 - Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis Phase 4
Completed NCT00740142 - Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy Phase 4
Completed NCT00914056 - A Study of Controlled Lactulose Withdrawal N/A
Completed NCT00558038 - Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy Phase 2
Completed NCT00986895 - A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group Phase 1
Completed NCT00287235 - Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) N/A
Recruiting NCT05539027 - Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy Phase 4
Recruiting NCT04096014 - Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy N/A
Completed NCT05526404 - Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration N/A
Completed NCT04082780 - Rifamycin in Minimal Hepatic Encephalopathy Phase 2
Enrolling by invitation NCT06367127 - Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening
Active, not recruiting NCT05425316 - Speech in Hepatic Encephalopathy (HE)
Recruiting NCT04415294 - Flicker App for Minimal Hepatic Encephalopathy
Not yet recruiting NCT06072521 - Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy Phase 2
Withdrawn NCT02086825 - A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure Phase 3
Completed NCT02636647 - Fecal Transplant in Recurrent Hepatic Encephalopathy Phase 1
Completed NCT01446523 - S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE N/A
Completed NCT01218568 - Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial N/A